Gary Taylor

Stock Analyst at TD Cowen

(2.59)
# 1,907
Out of 5,182 analysts
148
Total ratings
51.52%
Success rate
0.84%
Average return

Stocks Rated by Gary Taylor

Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44$25
Current: $27.58
Upside: -9.35%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40$42
Current: $19.26
Upside: +118.07%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45$13
Current: $2.90
Upside: +331.78%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $150$50
Current: $27.90
Upside: +79.21%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261$268
Current: $229.72
Upside: +16.66%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10$13
Current: $21.90
Upside: -40.64%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450$440
Current: $431.92
Upside: +1.87%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601$609
Current: $366.77
Upside: +66.04%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80$89
Current: $49.57
Upside: +79.54%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351$378
Current: $185.46
Upside: +103.82%
Maintains: Hold
Price Target: $183$220
Current: $162.54
Upside: +35.35%
Maintains: Hold
Price Target: $139$150
Current: $150.07
Upside: -0.05%
Maintains: Outperform
Price Target: $30$26
Current: $24.84
Upside: +4.67%
Upgrades: Outperform
Price Target: $39$35
Current: $14.35
Upside: +143.90%
Maintains: Outperform
Price Target: $564$585
Current: $362.74
Upside: +61.27%
Maintains: Market Perform
Price Target: $3$6
Current: $18.04
Upside: -66.74%
Maintains: Outperform
Price Target: $10$8
Current: $7.67
Upside: +4.30%
Upgrades: Outperform
Price Target: $242$329
Current: $284.92
Upside: +15.47%
Upgrades: Market Perform
Price Target: $7$3
Current: $2.64
Upside: +13.64%
Initiates: Market Perform
Price Target: $17
Current: $8.27
Upside: +105.56%
Downgrades: Underweight
Price Target: $28$20
Current: $177.50
Upside: -88.73%
Maintains: Neutral
Price Target: $33$20
Current: $22.96
Upside: -12.89%
Downgrades: Underweight
Price Target: n/a
Current: $2.88
Upside: -